Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Purchases in this page22
Other acquisitions28
Reporting owners39
SalesNot providedCheck original SEC filings
Sep 29, 2025 – Nov 25, 2025 · Transaction dates · Current page sample
Reported quantity · security units
SmartRent, Inc. · Class A Common Stock · Purchase (code P) · Non-derivative · Currency not specified
Swipe the chart to see the full date range. Exact records are available in the table below.
2 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
50 dated transactions in this page sample · 39 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 925,000 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 700,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 350,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 150,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 100,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 50,041 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 135,134 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 473,334 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 239,703 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Russo Rene (PRESIDENT AND CEO · Director) | Stock award | 2,075,000 | 0 | 0 | Currency not specified |
| Nov 25, 2025 | Eastern Bankshares, Inc.Common Stock | Sullivan Michael James (Director) | Exercise / conversion | 13,696 | 13.38 | 183,252.48 | Currency not specified |
| Nov 25, 2025 | SmartRent, Inc.Class A Common Stock | Martell Frank (Chief Executive Officer · Director) | Purchase | 50,435 | 1.725 | 87,000.375 | Currency not specified |
| Nov 24, 2025 | SmartRent, Inc.Class A Common Stock | Martell Frank (Chief Executive Officer · Director) | Purchase | 49,565 | 1.6037 | 79,487.3905 | Currency not specified |
| Sep 29, 2025 | Cue Biopharma, Inc.Stock Option (right to buy) | Warren Lucinda (CHIEF BUSINESS OFFICER) | Stock award | 125,000 | 0 | 0 | Currency not specified |
| Sep 29, 2025 | Cue Biopharma, Inc.Stock Option (right to buy) | Baker Daniel G. (CHIEF DEVELOPMENT OFFICER) | Stock award | 50,000 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | ADTRAN Holdings, Inc.Common Stock | STANTON THOMAS R (Chairman & CEO · Director) | Purchase | 40,928 | 7.33 | 300,002.24 | Currency not specified |
| Nov 22, 2025 | MBX Biosciences, Inc.Stock option (right to buy) | Hoerter Steven L. (Director) | Stock award | 8,000 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | Aon plcClass A Ordinary Stock | Corona Anne (Chief Commercial Officer) | Exercise / conversion | 132 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Aon plcClass A Ordinary Stock | Goltermann Lori (CEO, Regions & North America) | Exercise / conversion | 156 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Aon plcClass A Ordinary Stock | Marcell Andy (Global CEO, Solution Lines) | Exercise / conversion | 86 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Olema Pharmaceuticals, Inc.Common Stock | RAPPAPORT ANDREW (Director) | Exercise / conversion | 35,868 | 0.39 | 13,988.52 | Currency not specified |
| Nov 24, 2025 | ReposiTrak, Inc.Common Stock | FIELDS RANDALL K (CHIEF EXECUTIVE OFFICER · Director · 10% owner) | Gift received | 200,000 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | Epsilon Energy Ltd.Common Shares | Lawrence Bryan H. (Director) | Stock award | 2,234,847 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | NUSCALE POWER CorpClass A Common Stock | FLUOR CORP (Director · 10% owner) | Conversion | 463,747 | Not reported | Not reported | Currency not specified |
| Nov 22, 2025 | Amcor plcOrdinary Shares | FOSTER JONATHAN F (Director) | Exercise / conversion | 15,167 | 0 | 0 | Currency not specified |
| Nov 25, 2025 | UNITED THERAPEUTICS CorpCommon Stock | ROTHBLATT MARTINE A (Chairperson & CEO · Director) | Exercise / conversion | 4,000 | 120.26 | 481,040 | Currency not specified |
| Nov 24, 2025 | UNITED THERAPEUTICS CorpCommon Stock | ROTHBLATT MARTINE A (Chairperson & CEO · Director) | Exercise / conversion | 4,000 | 120.26 | 481,040 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Schoeneberg Carey Denise (SVP & Chief Risk Officer) | Purchase | 100 | 21 | 2,100 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Schoeneberg Carey Denise (SVP & Chief Risk Officer) | Purchase | 1,000 | 21 | 21,000 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | KRUSE CHARLES E (Director) | Purchase | 2,500 | 21 | 52,500 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Westhues Daniel Harold (SEVP & Chief Customer Officer) | Purchase | 4,200 | 21 | 88,200 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Thompson Tristan Antin (See Remarks.) | Purchase | 480 | 21 | 10,080 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Sprong Bradley Nixon (Director) | Purchase | 4,500 | 21 | 94,500 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Ross John Thomas (President, CEO · Director) | Purchase | 42,000 | 21 | 882,000 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Robuck Robert Marion (Director) | Purchase | 47,619 | 21 | 999,999 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Robertson Edward Deroy Jr. (Director) | Purchase | 4,550 | 21 | 95,550 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | McClure Richard Hays (Director) | Purchase | 11,200 | 21 | 235,200 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Kellett Scott McKinney (EVP of Wealth Management) | Purchase | 1,000 | 21 | 21,000 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Hermann Robert Ringen Jr. (Director) | Purchase | 47,619 | 21 | 999,999 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Hallgren Eric Andrew (EVP & Chief Credit Officer) | Purchase | 2,500 | 21 | 52,500 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Goldammer Russell Lee (EVP & CIO) | Purchase | 2,000 | 21 | 42,000 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Cook Sam Bryan (Executive Chairman · Director · 10% owner) | Purchase | 9,000 | 21 | 189,000 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Cook Sam Bryan (Executive Chairman · Director · 10% owner) | Purchase | 38,619 | 21 | 810,999 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Digges Charles William Jr. (Director) | Purchase | 5,000 | 21 | 105,000 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Colbert Jeremy Wayne (See Remarks.) | Purchase | 2,200 | 21 | 46,200 | Currency not specified |
| Nov 21, 2025 | Central Bancompany, Inc.Class A Common Stock | Ciroli James (EVP & CFO) | Purchase | 17,000 | 21 | 357,000 | Currency not specified |
| Nov 21, 2025 | Dogwood Therapeutics, Inc.Common Stock | CK Life Sciences Intl (Holdings) Inc (Director · 10% owner · See Remarks) · Sealbond Ltd (Director · 10% owner · See Remarks) · Conjoint Inc. (Director · 10% owner · See Remarks) | Conversion | 2,842,638 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Dogwood Therapeutics, Inc.Common Stock | CK Life Sciences Intl (Holdings) Inc (Director · 10% owner · See Remarks) · Sealbond Ltd (Director · 10% owner · See Remarks) · Conjoint Inc. (Director · 10% owner · See Remarks) | Conversion | 21,610,950 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Verastem, Inc.Common Stock | Bunn Paul A. (Director) | Exercise / conversion | 6,250 | 3.27 | 20,437.5 | Currency not specified |
| Nov 21, 2025 | Robinhood Markets, Inc.Variable Share Forward Contract (obligation to sell) | Malka Meyer (Director) | Other acquisition | 1,000,000 | Not reported | Not reported | Currency not specified |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 925,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 700,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 350,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 150,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 100,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 50,041 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 135,134 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 473,334 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 239,703 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Russo RenePRESIDENT AND CEO · Director | Stock awardStock Option (right to buy)Derivative security · Code A | 2,075,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Eastern Bankshares, Inc.EBC · company listings | Sullivan Michael JamesDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 13,696 | 13.38Value: 183,252.48Currency not specified | View ↗ |
| Trade: | SmartRent, Inc.SMRT · company listings | Martell FrankChief Executive Officer · Director | PurchaseClass A Common StockNon-derivative security · Code P | 50,435 | 1.725 *Value: 87,000.375Currency not specified | View ↗ |
| Trade: | SmartRent, Inc.SMRT · company listings | Martell FrankChief Executive Officer · Director | PurchaseClass A Common StockNon-derivative security · Code P | 49,565 | 1.6037 *Value: 79,487.3905Currency not specified | View ↗ |
| Trade: | Cue Biopharma, Inc.CUE · company listings | Warren LucindaCHIEF BUSINESS OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 125,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cue Biopharma, Inc.CUE · company listings | Baker Daniel G.CHIEF DEVELOPMENT OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | ADTRAN Holdings, Inc.ADTN · company listings | STANTON THOMAS RChairman & CEO · Director | PurchaseCommon StockNon-derivative security · Code P | 40,928 | 7.33 *Value: 300,002.24Currency not specified | View ↗ |
| Trade: | MBX Biosciences, Inc.MBX · company listings | Hoerter Steven L.Director | Stock awardStock option (right to buy)Derivative security · Code A | 8,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Aon plcAON · company listings | Corona AnneChief Commercial Officer | Exercise / conversionClass A Ordinary StockNon-derivative security · Code M | 132 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Aon plcAON · company listings | Goltermann LoriCEO, Regions & North America | Exercise / conversionClass A Ordinary StockNon-derivative security · Code M | 156 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Aon plcAON · company listings | Marcell AndyGlobal CEO, Solution Lines | Exercise / conversionClass A Ordinary StockNon-derivative security · Code M | 86 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Olema Pharmaceuticals, Inc.OLMA · company listings | RAPPAPORT ANDREWDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 35,868 | 0.39Value: 13,988.52Currency not specified | View ↗ |
| Trade: | ReposiTrak, Inc.TRAK · company listings | FIELDS RANDALL KCHIEF EXECUTIVE OFFICER · Director · 10% owner | Gift receivedCommon StockNon-derivative security · Code G | 200,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Epsilon Energy Ltd.EPSN · company listings | Lawrence Bryan H.Director | Stock awardCommon SharesNon-derivative security · Code A | 2,234,847 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | NUSCALE POWER CorpSMR · company listings | FLUOR CORPDirector · 10% owner | ConversionClass A Common StockNon-derivative security · Code C | 463,747 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Amcor plcAMCR · company listings | FOSTER JONATHAN FDirector | Exercise / conversionOrdinary SharesNon-derivative security · Code M | 15,167 | 0 *Value: 0Currency not specified | View ↗ |
| Trade: | UNITED THERAPEUTICS CorpUTHR · company listings | ROTHBLATT MARTINE AChairperson & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 4,000 | 120.26Value: 481,040Currency not specified | View ↗ |
| Trade: | UNITED THERAPEUTICS CorpUTHR · company listings | ROTHBLATT MARTINE AChairperson & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 4,000 | 120.26Value: 481,040Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Schoeneberg Carey DeniseSVP & Chief Risk Officer | PurchaseClass A Common StockNon-derivative security · Code P | 100 | 21Value: 2,100Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Schoeneberg Carey DeniseSVP & Chief Risk Officer | PurchaseClass A Common StockNon-derivative security · Code P | 1,000 | 21Value: 21,000Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | KRUSE CHARLES EDirector | PurchaseClass A Common StockNon-derivative security · Code P | 2,500 | 21Value: 52,500Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Westhues Daniel HaroldSEVP & Chief Customer Officer | PurchaseClass A Common StockNon-derivative security · Code P | 4,200 | 21Value: 88,200Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Thompson Tristan AntinSee Remarks. | PurchaseClass A Common StockNon-derivative security · Code P | 480 | 21Value: 10,080Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Sprong Bradley NixonDirector | PurchaseClass A Common StockNon-derivative security · Code P | 4,500 | 21Value: 94,500Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Ross John ThomasPresident, CEO · Director | PurchaseClass A Common StockNon-derivative security · Code P | 42,000 | 21Value: 882,000Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Robuck Robert MarionDirector | PurchaseClass A Common StockNon-derivative security · Code P | 47,619 | 21Value: 999,999Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Robertson Edward Deroy Jr.Director | PurchaseClass A Common StockNon-derivative security · Code P | 4,550 | 21Value: 95,550Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | McClure Richard HaysDirector | PurchaseClass A Common StockNon-derivative security · Code P | 11,200 | 21Value: 235,200Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Kellett Scott McKinneyEVP of Wealth Management | PurchaseClass A Common StockNon-derivative security · Code P | 1,000 | 21Value: 21,000Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Hermann Robert Ringen Jr.Director | PurchaseClass A Common StockNon-derivative security · Code P | 47,619 | 21Value: 999,999Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Hallgren Eric AndrewEVP & Chief Credit Officer | PurchaseClass A Common StockNon-derivative security · Code P | 2,500 | 21Value: 52,500Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Goldammer Russell LeeEVP & CIO | PurchaseClass A Common StockNon-derivative security · Code P | 2,000 | 21Value: 42,000Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Cook Sam BryanExecutive Chairman · Director · 10% owner | PurchaseClass A Common StockNon-derivative security · Code P | 9,000 | 21Value: 189,000Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Cook Sam BryanExecutive Chairman · Director · 10% owner | PurchaseClass A Common StockNon-derivative security · Code P | 38,619 | 21Value: 810,999Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Digges Charles William Jr.Director | PurchaseClass A Common StockNon-derivative security · Code P | 5,000 | 21Value: 105,000Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Colbert Jeremy WayneSee Remarks. | PurchaseClass A Common StockNon-derivative security · Code P | 2,200 | 21Value: 46,200Currency not specified | View ↗ |
| Trade: | Central Bancompany, Inc.CBC · company listings | Ciroli JamesEVP & CFO | PurchaseClass A Common StockNon-derivative security · Code P | 17,000 | 21Value: 357,000Currency not specified | View ↗ |
| Trade: | Dogwood Therapeutics, Inc.DWTX · company listings | CK Life Sciences Intl (Holdings) IncDirector · 10% owner · See Remarks Sealbond LtdDirector · 10% owner · See Remarks Conjoint Inc.Director · 10% owner · See Remarks Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 2,842,638 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Dogwood Therapeutics, Inc.DWTX · company listings | CK Life Sciences Intl (Holdings) IncDirector · 10% owner · See Remarks Sealbond LtdDirector · 10% owner · See Remarks Conjoint Inc.Director · 10% owner · See Remarks Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 21,610,950 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Verastem, Inc.VSTM · company listings | Bunn Paul A.Director | Exercise / conversionCommon StockNon-derivative security · Code M | 6,250 | 3.27Value: 20,437.5Currency not specified | View ↗ |
| Trade: | Robinhood Markets, Inc.HOOD · company listings | Malka MeyerDirector | Other acquisitionVariable Share Forward Contract (obligation to sell)Derivative security · Code J | 1,000,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →